Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: A systematic review and meta-analysis

General Hospital Psychiatry

Volumn 32, Issue 4, 2010, Pages 380-395

  van der Feltz Cornelis, Christina M ^a,b   Nuyen, Jasper ^a   Stoop, Corinne ^a,b   Chan, Juliana ^c   Jacobson, Alan M ^d,e   Katon, Wayne ^f   Snoek, Frank ^g   Sartorius, Norman ^h,i  

^a NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d HARVARD MEDICAL SCHOOL   (United States)

^e WINTHROP UNIVERSITY HOSPITAL   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h Action for Mental Health   (Switzerland)

ⁱ UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Depression; Diabetes mellitus; Glycemic control; Meta analysis; Systematic review; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SERTRALINE; GLUCOSE BLOOD LEVEL;

ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DEPRESSION; DIABETES EDUCATION; DISEASE SEVERITY; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR DEPRESSION; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SELF CARE; SYMPTOM; SYSTEMATIC REVIEW; ANALYSIS; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; PSYCHOLOGY; PSYCHOTHERAPY; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; BLOOD GLUCOSE; DEPRESSIVE DISORDER, MAJOR; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 77954620551     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2010.03.011     Document Type: Article

References (74)

1. Ali S., Stone M.A., Peters J.L., Davies M.J., Khunti K. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med 2006, 23:1165-1173.
2. Egede L.E., Zheng D., Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002, 25:464-470.
3. Egede L.E. Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 2004, 27:421-428.
4. Goldney R.D., Phillips P.J., Fisher L.J., Wilson D.H. Diabetes, depression, and quality of life: a population study. Diabetes Care 2004, 27:1066-1070.
5. Von Korff M., Katon W., Lin E.H., Simon G., Ciechanowski P., Ludman E., et al. Work disability among individuals with diabetes. Diabetes Care 2005, 28:1326-1332.
6. Barnard K.D., Skinner T.C., Peveler R. The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review. Diabet Med 2006, 23:445-448.
7. Lustman P.J., Clouse R.E., Ciechanowski P.S., Hirsch I.B., Freedland K.E. Depression-related hyperglycemia in Type 1 diabetes: a mediational approach. Psychosom Med 2005, 67:195-199.
8. de Groot M., Jacobson A.M., Samson J.A., Welch G. Glycemic control and major depression in patients with Type 1 and Type 2 diabetes mellitus. J Psychosom Res 1999, 46:425-435.
9. Lloyd C.E., Dyer P.H., Barnett A.H. Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabet Med 2000, 17:198-202.
10. Van Tilburg M.A., McCaskill C.C., Lane J.D., Edwards C.L., Bethel A., Feinglos M.N., et al. Depressed mood is a factor in glycemic control in Type 1 diabetes. Psychosom Med 2001, 63:551-555.
11. Ciechanowski P.S., Katon W.J., Russo J.E., Hirsch I.B. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry 2003, 25:246-252.
12. Forrest K.Y.Z., Becker D.J., Kuller L.H., Wolfson S.K., Orchard T.J. Are predictors of coronary heart disease and lower-extremity arterial disease in Type 1 diabetes the same?: A prospective study. Atherosclerosis 2000, 148:159-169.
13. Lloyd C.E., Kuller L.H., Ellis D., Becker D.J., Wing R.R., Orchard T.J. Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol 1996, 16:720-726.
14. Kinder L.S., Kamarck T.W., Baum A., Orchard T.J. Depressive symptomatology and coronary heart disease in Type I diabetes mellitus: a study of possible mechanisms. Health Psychol 2002, 21:542-552.
15. Kovacs M., Mukerji P., Drash A., Iyengar S. Biomedical and psychiatric risk factors for retinopathy among children with IDDM. Diabetes Care 1995, 18:1592-1599.
16. Black S.A., Markides K.S., Ray L.A. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with Type 2 diabetes. Diabetes Care 2003, 26:2822-2828.
17. Hermanns N., Kulzer B., Krichbaum M., Kubiak T., Haak T. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia 2006, 49:469-477.
18. Nuyen J., Spreeuwenberg P.M., Van Dijk L., den Bos G.A., Groenewegen P.P., Schellevis F.G. The influence of specific chronic somatic conditions on the care for co-morbid depression in general practice. Psychol Med 2008, 38:265-277.
19. Pouwer F., Beekman A.T., Lubach C., Snoek F.J. Nurses' recognition and registration of depression, anxiety and diabetes-specific emotional problems in outpatients with diabetes mellitus. Patient Educ Couns 2006, 60:235-240.
20. Rubin R.R., Ciechanowski P., Egede L.E., Lin E.H., Lustman P.J. Recognizing and treating depression in patients with diabetes. Curr Diab Rep 2004, 4:119-125.
21. Katon W.J., Simon G., Russo J., Von Korff M., Lin E.H., Ludman E., et al. Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care 2004, 42:1222-1229.
22. Krishnan K.R.R. Treatment of depression in the medically III. J Clin Psychopharmacol 2005, 25:S14-S18.
23. Carney C. Diabetes mellitus and major depressive disorder: an overview of prevalence, complications, and treatment. Depress Anxiety 1998, 7:149-157.
24. Goodnick P.J. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry 2001, 13:31-41.
25. Lustman P.J., Clouse R.E. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 2005, 19:113-122.
26. Musselman D.L., Betan E., Larsen H., Phillips L.S. Relationship of depression to diabetes Types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003, 54:317-329.
27. Pirraglia P.A., Gupta S. The interaction of depression and diabetes: a review. Curr Diabetes Rev 2007, 3:249-251.
28. Snoek F.J., Skinner T.C. Psychological counselling in problematic diabetes: does it help?. Diabet Med 2002, 19:265-273.
29. Steed L., Cooke D., Newman S. A systematic review of psychosocial outcomes following education, self-management and psychological interventions in diabetes mellitus. Patient Educ Couns 2003, 51:5-15.
30. Stewart S.M., Rao U., White P. Depression and diabetes in children and adolescents. Curr Opin Pediatr 2005, 17:626-631.
31. Fisher E.B., Thorpe C.T., Devellis B.M., Devellis R.F. Healthy coping, negative emotions, and diabetes management: a systematic review and appraisal. Diabetes Educ 2007, 33:1080-1103.
32. Wang M.Y., Tsai P.S., Chou K.R., Chen C.M. A systematic review of the efficacy of non-pharmacological treatments for depression on glycaemic control in Type 2 diabetics. J Clin Nurs 2008, 17:2524-2530.
33. Petrak F., Herpertz S. Treatment of depression in diabetes- an update 2008.
34. Gregoire G., Derderian F., Le L.J. Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias?. J Clin Epidemiol 1995, 48:159-163.
35. Van der Feltz-Cornelis C.M., Ader H.J. Randomization in psychiatric intervention research in the general practice setting. Int J Methods Psychiatr Res 2000, 9:134-142.
36. McGuire H., Moncrieff J., Churchill R. International Cochrane Colloquium: quality assessment of trials found within the scope of Cochrane Collaboration Depression, Anxiety & Neurosis (CCDAN) 1998, 81.
37. Borenstein M., Hedges L.V., Higgins J.P.T., Rothstein H.R. Comprehensive meta-analysis 2005, Biostat, Englewood (NJ).
38. Guy W. ECDEU Assessment Manual for Psychopharmacology-Revised; DHEW Publ No ADM 76-338 1976, 218-222. NIMH, Rockville (MD).
39. Borenstein M., Hedges L.V., Higgins J.P.T., Rothstein H.R. Comprehensive Meta-Analysis, Version 2 2005, Biostat, Englewood (NJ).
40. Katon W., Lin E.H., Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007, 29:147-155.
41. Ludman E.J., Katon W., Russo J., Von Korff M., Simon G., Ciechanowski P., et al. Depression and diabetes symptom burden. Gen Hosp Psychiatry 2004, 26:430-436.
42. Adriaanse M.C., Pouwer F., Dekker J.M., Nijpels G., Stehouwer C.H., Heine R.J., et al. Diabetes-related symptom distress in association with glucose metabolism and comorbidity: the Hoorn Study. Diabetes Care 2008, 31:2268-2270.
43. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
44. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. Bmj 2003, 327:557-560.
45. Begg C.B. The handbook of research synthesis. Publication bias 1994, 399-409. Russel Sage Foundation, New York. H. Cooper, L.V. Hedges (Eds.).
46. Rothstein H.R., Sutton A.J., Borenstein M. Publication bias in meta-analysis: prevention, assessment and adjustments 2005, Wiley & Sons, Chicester, UK.
47. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gãtzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Plos Med 2009, 6(7):e1000100. Electronic Publication 2009.
48. Gulseren L., Gulseren S., Hekimsoy Z., Mete L. Comparison of fluoxetine and paroxetine in Type II diabetes mellitus patients. Arch Med Res 2005, 36:159-165.
49. Katon W.J., Von Korff M., Lin E.H., Simon G., Ludman E., Russo J., et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004, 61:1042-1049.
50. Lustman P.J., Freedland K.E., Griffith L.S., Clouse R.E. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 2000, 23:618-623.
51. Lustman P.J., Griffith L.S., Freedland K.E., Kissel S.S., Clouse R.E. Cognitive behavior therapy for depression in Type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1998, 129:613-621.
52. Lustman P.J., Griffith L.S., Clouse R.E., Freedland K.E., Eisen S.A., Rubin E.H., et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997, 59:241-250.
53. Paile-Hyvarinen M., Wahlbeck K., Eriksson J.G. Quality of life and metabolic status in mildly depressed women with Type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial. BMC Fam Pract 2003, 4:7.
54. Paile-Hyvarinen M., Wahlbeck K., Eriksson J.G. Quality of life and metabolic status in mildly depressed patients with Type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial. BMC Fam Pract 2007, 8-34.
55. Simson U., Nawarotzky U., Friese G., Porck W., Schottenfeld-Naor Y., Hahn S., et al. Psychotherapy intervention to reduce depressive symptoms in patients with diabetic foot syndrome. Diabet Med 2008, 25:206-212.
56. Williams J.W., Katon W., Lin E.H., Noel P.H., Worchel J., Cornell J., et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004, 140:1015-1024.
57. Ell K., Katon W.J., Cabassa L.J., Xie B., Lee P.J., Kapetanovic s., et al. Depression and diabetes among low-income hispanics: design elements of a socioculturally adapted collaborative care model randomized controlled trial. int'L. J Psychiatry Med 2009, 39:113-132.
58. Echeverry D., Duran P., Bonds C., Lee M., Davidson M.B. The effect of pharmacologic treatment of depression on A1C and quality of life in low income Hispanics and African Americans with diabetes: a randomized, double blind, placebo controlled trial. Diabetes Care 2009 Dec, 32(12):2156-2160.
59. Huang X., Song L., Li T., Li J., Wu S., Li N. Effect of health education and psychosocial intervention on depression in patients with Type II diabetes. Chin Ment Health J 2002, 16:149-151.
60. Li S.C., Li M., Song S.J., et al. The effect of psychological intervention in treating the diabetic patients with negative emotion. Shandong J Psychol Med 2003, 16:148.
61. Lu X.s., Lu B.x., Gu X. Cognitive therapy in combination with electromyographic feedback in treatment of diabetes patients with depression after cerebral infarction. Chin J Clin Psychol 2005, 13:215-216.
62. Xue H. Paroxetine for depression in diabetes: a randomized controlled trial. Chinese Ment Health J 2004, 18:735-737.
63. Ell K., Xie B., Quon B., Quinn D.I., Dwight-Johnson M., Lee P.J. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol 2008, 26(27):4488-4496.
64. Hedges L.V., Olkin I. Statistical methods for meta-analysis 1985, Academic Press, Orlando.
65. Lipsey M.W. Design sensitivity: statistical power for experimental research 1990, Sage, Newbury Park.
66. Lipsey M.W., Wilson D.B. The efficacy of psychological, educational, and behavioral treatment. Confirmation from meta-analysis. Am Psychol 1993, 48:1181-1209.
67. Andersohn F., Schade R., Suissa S., Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry 2009, 166:591-598.
68. Rubin R.R., Ma Y., Marrero D.G., Peyrot M., Barrett-Connor E.L., Kahn S.E., et al. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 2008, 31:420-426. Diabetes Prevention Program Research Group.
69. Petty R., Sensky T., Mahler R. Diabetologists' assessments of their outpatients' emotional state and health beliefs: accuracy and possible sources of bias. Psychother Psychosom 1991, 155:164-169.
70. Fava G.A., Tomba E., Grandi S. The road to recovery from depression - don't drive today with yesterday's map. Psychother Psychosom 2007, 76:260-265.
71. Gaynes B.N., Rush A.J., Trivedi M.H., Wisniewski S.R., Balasubramani G.K., McGrath P.J., et al. Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D. J Gen Intern Med 2008, 551-560.
72. Dunn J.D., Tierneey J.G. A step therapy algorithm for the treatment and management of chronic depression. Am J Manag Care 2006, 12:S335-S343.
73. Kleinman A.M. Depression, somatization and the new cross-cultural psychiatry. Soc Sci Med 1977, 11:3-10.
74. Gonzalez J.S., Peyrot M., McCarl L.A., Collins E.M., Serpa L., Mimiaga M.J., et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 2008, 31:2398-2403.